CHAR Technologies will present to investors at the Smallcap Discoveries Conference in Vancouver on Monday, September 29, where CEO Andrew White is slated for a 2:15 to 2:45 p.m. slot at the JW Marriott Parq Hotel.
The company said the talk will focus on progress at its Thorold renewable natural gas and biocarbon facility and what to expect as the project moves from construction to commercial operations.
The event is a draw for dedicated microcap investors, which gives smaller issuers a concentrated forum to explain milestones and funding paths.
The Toronto-based company, which trades on the TSX Venture Exchange under the symbol YES, develops high-temperature pyrolysis systems that turn low-value wood and organic residues into biocarbon and renewable gas.
In its presentation notice, CHAR said Phase 1 of the Thorold facility remains on track to be online by year-end 2025, with first commercial biocarbon revenues expected in 2026.
The company also plans to lay out timelines for integrating Phase 2 renewable natural gas production in 2026, which would shift the project from single-stream biocarbon sales to combined biocarbon and RNG cash flows.
The update matters for investors who have been watching construction milestones and offtake visibility as indicators of execution risk.
Thorold has featured prominently in CHAR’s financing news this year. In July, the company announced an $8 million project-level equity investment from The BMI Group that resulted in 50-50 ownership of the facility between CHAR and BMI.
The partners said the equity commitments for Phase 1 were in place, with efforts underway to secure non-recourse project debt that would support Phase 2 and keep RNG commissioning targeted toward late third quarter 2026.
That structure reduces corporate-level dilution and aligns capital with project stages, but it also sets clear deadlines that will be watched closely as equipment installation and commissioning continue for investors.
The Thorold plan has drawn interest from heavy industry, which is searching for low-carbon substitutes for fossil fuels.
CHAR has highlighted biocarbon as a potential drop-in replacement for portions of metallurgical coal used in steelmaking, while RNG offers an avenue to monetize syngas upgrading through existing utility networks.
Those pathways are central to the company’s pitch that waste-derived feedstocks can support decarbonization without requiring major process overhauls by end users.
Execution will still hinge on feedstock logistics, uptime through commissioning, and the cadence of offtake ramp-ups once the plant begins producing at commercial scale.
Smallcap Discoveries conferences cater to a community that often does its own primary research and follows catalysts closely.
For CHAR, a live slot creates an opportunity to clarify how late-2025 commissioning will translate into 2026 revenue recognition, what contingency buffers exist if equipment timelines slip, and how Phase 2 capital needs will be met if credit markets tighten.
Investors will also look for any color on contract structures for biocarbon deliveries and RNG offtake, both of which affect project cash conversion and financing costs.
Microcap shares can move sharply around conference season because new information reaches a concentrated audience of active buyers and sellers.
CHAR has previously signaled long-term offtake partnerships and a step-down in construction risk as Phase 1 nears completion. Converting that narrative into realized tonnage and gas volumes is the next test.
Clear commissioning checkpoints, transparent disclosure on any schedule changes, and evidence of stable feedstock supply can help bridge the gap from promise to performance.
Investors who follow early-stage clean energy platforms know the pivot from build to operate is often the most volatile phase for a stock.
The Thorold facility’s first revenues, if delivered on the timetable the company has guided, would provide tangible proof of demand for biocarbon and a foundation to finance the RNG expansion without overreliance on equity.
Conversely, delays or higher-than-expected commissioning costs could compress near-term liquidity and force recalibration of growth plans.
That is why conference appearances like this one tend to draw close scrutiny: they can sharpen the timeline and give the market a firmer basis for valuation.
CHAR’s presentation in Vancouver will be a chance to show whether the Thorold project is positioned to meet its year-end goals and to answer detailed questions from a crowd that tracks microcap catalysts by the week.
With the commissioning window approaching and the next leg of financing under discussion, the message and the numbers will both matter.
